BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27003684)

  • 1. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
    Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X
    Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p.
    Yan C; Li J; Feng S; Li Y; Tan L
    Cell Death Dis; 2018 Feb; 9(3):289. PubMed ID: 29459686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
    Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
    Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
    Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
    Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression.
    Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W
    Int J Mol Med; 2019 Jan; 43(1):345-357. PubMed ID: 30431065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1.
    Wang S; Ai H; Liu L; Zhang X; Gao F; Zheng L; Yi J; Sun L; Yu C; Zhao H; Li Y
    Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E911-E924. PubMed ID: 31526292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
    Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
    Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin F
    Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
    Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-721 regulates gluconeogenesis via KDM2A-mediated epigenetic modulation in diet-induced insulin resistance in C57BL/6J mice.
    Kabeer SW; Sharma S; Sriramdasu S; Tikoo K
    Biol Res; 2024 May; 57(1):27. PubMed ID: 38745315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
    Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
    Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
    Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
    Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
    [No Abstract]   [Full Text] [Related]  

  • 12. Leptin suppresses microRNA-122 promoter activity by phosphorylation of foxO1 in hepatic stellate cell contributing to leptin promotion of mouse liver fibrosis.
    Cao Q; Zhu X; Zhai X; Ji L; Cheng F; Zhu Y; Yu P; Zhou Y
    Toxicol Appl Pharmacol; 2018 Jan; 339():143-150. PubMed ID: 29248466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance.
    Song Y; Wu L; Li M; Xiong X; Fang Z; Zhou J; Yan G; Chen X; Yang J; Li Y
    EBioMedicine; 2019 Apr; 42():494-503. PubMed ID: 30948354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
    Tian F; Ying HM; Wang YY; Cheng BN; Chen J
    Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.
    Tong X; Zhang D; Charney N; Jin E; VanDommelen K; Stamper K; Gupta N; Saldate J; Yin L
    Diabetes; 2017 Oct; 66(10):2571-2582. PubMed ID: 28790135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.
    Yan H; Yang W; Zhou F; Li X; Pan Q; Shen Z; Han G; Newell-Fugate A; Tian Y; Majeti R; Liu W; Xu Y; Wu C; Allred K; Allred C; Sun Y; Guo S
    Diabetes; 2019 Feb; 68(2):291-304. PubMed ID: 30487265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK).
    Sun WX; Lou K; Chen LJ; Liu SD; Pang SG
    J Endocrinol Invest; 2021 Aug; 44(8):1753-1765. PubMed ID: 33423221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis.
    Kurano M; Hara M; Satoh H; Tsukamoto K
    Metabolism; 2015 May; 64(5):588-96. PubMed ID: 25660144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice.
    Cui Y; Qiao A; Jiao T; Zhang H; Xue Y; Zou Y; Cui A; Fang F; Chang Y
    Diabetologia; 2016 Oct; 59(10):2229-39. PubMed ID: 27421728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis.
    Liang J; Liu C; Qiao A; Cui Y; Zhang H; Cui A; Zhang S; Yang Y; Xiao X; Chen Y; Fang F; Chang Y
    J Hepatol; 2013 Mar; 58(3):535-42. PubMed ID: 23111009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.